Clinical trial
Intravenous Ghrelin Infusion Decreases Insulin Sensitivity in Healthy Young Men
NCT00512525 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravenous Ghrelin Infusion Decreases Insulin Sensitivity in Healthy Young Men
- Lead sponsor
- University of Aarhus
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2003
- Completion date
- October 31, 2003
- Enrollment
- 8 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
healthy subjects